- NewsCategory：
- All Company news Industry news
common83One result
-
1030
Gilead and Glympse Bio Announce Strategic C↔¶ollaboration for Use of Biomarker Tech↔ ±nology in NASH Clinical Developmenβ☆t
Gilead and Glympse Bio Announce Strategic Collabo₩≤ration for Use of Biomarker Tec∑¥↕hnology in NASH Clinical DevelopmentTUE™→✔SDAY, OCTOBER 29, 2019Gilead Sciences Inc. anΩ∑d Glympse Bio, Inc., today announced that ₽φ☆πthe companies have entered into a str∑♦ategic collaboration in nonalcoholic steatohepati✘≈εtis (NASH) clinical development. Glympse Bio↑←’s proprietary synthe¶•∏tic biomarkers – bioengineered to identify stag↕€e and progression of disease as well as early₹♥↔ detection of treatment response –" γ will be used to determine clinical tr←§ial participants’ stage£" of disease at initial sc↕¥reening and to determine reδ↔sponses to study treatment in Gilead’s NASH c®λlinical program.“We are excited about th☆¶↑e opportunity to partner with Glympse Bio ♣♦to help inform our NASH development program,” ≠←said Mani Subramanian, MD, $♣©PhD Senior Vice President, Liver Diseases, Gi≈÷±lead Sciences. “By utilizing th↔☆is innovative technology, we hope to b₹♣₩etter characterize th±≈is complex disease and improve ou"¥¥r understanding of how our com≠'pounds impact disease progression.”G♥≈lympse Bio’s proprietary technolog∑δy, Glympse Inside™, combin×&es synthetic biomarkers with machine leaα ↕rning approaches to identifδφγy the stage and monitor ®β>÷progression of important, comple¶≤★ x diseases such as cancer∑↓, fibrosis, inflammation×≈σβ, and infections, in real time.≤π€$“We are very excited a≈λbout partnering with Gilead, a l€€<eader in drug development, to help drive e☆> arlier and more favorable o≥✘$©utcomes for patients,” sai✘∞d Caroline J Loew, President and CEO, Glymp≥&se Bio. “Gilead’s commitment to d≤λφ∞eveloping innovative medic<∞ines in areas of high unmet medical need ali↓ ↔>gns with our mission of transformiλ•δng disease detection and ₩"≥∞measuring treatment responsδ↕e, all with the goal of helping improve the ≤©αlives of patients.”informat>♥♥ion source:pharma focus Asi∑λ$δaThe original link:https:https:https://www.pharmλ ¶afocusasia.com/news/gilead-λ©♣and-glympse-bio-announce-strategic-colla•₽§εboration-for-use-of-biomarke÷₽r-technology-in-nash-clinical-develo Ωpment2019 Asia-pacific pharβ≥₽ma IP Leader Summit:http://en.zenseegroΩ<£up.com/p/510934/ will be held in&₽®nbsp;Beijing on •∞;November 14-15, and ≥will attract more than 500 industry expeλσ×rts from domestic and foreign pharmaceutical c®γ₽ ompanies, biotechnology companie€¥ ®s, governments, associations, law πσ☆firms, intellectual property agentΩγs and other companies to$↕★§ attend.Official registration a™≥nd consultation channels:Contact：A π'nnPhone: 021-65650305Email：Marketin∞© g@zenseegroup.comhttp://en.zenseegro☆ ♣up.com/p/510934 -
1031
Gotham Therapeutics Establisheδ✔s Advanced Oncology Profiling Cascade with₹Ωε ProQinase to Progress its Portfolφ&io of Epitranscriptomic Drug Candidates
Gotham Therapeutics Establishes A¥✔dvanced Oncology Profiling Cascade₽≤ ≤ with ProQinase to Progress its Portfol♥δΩio of Epitranscriptomic Drug Candi₹$datesWEDNESDAY, OCTOBER 30, 2019Go€ $tham Therapeutics, a biotechnology↓★★π company developing a novel dr< ∑$ug class targeting RNA-modifying proteins, an≥☆d ProQinase, an early stage drug-discover£™y company, recently acquired by ♦¶Malvern/PA-based Reaction Biology Corp., tod≈§®ay announced that they have established an a∑&rray of advanced biochemical and cellular as←αsays to characterize epitranscriptomic≥•÷-directed compounds.“Es∑♦εΩtablishing tailored targe"÷t engagement, cell biology, phenotypic,δ♥π and in-vivo assays to evaluate ®γcompounds originating from •®↓our three most advanced epitranscriptomic pr÷♦αograms in parallel is aβδ♠¶ crucial next step to developΩ≤♣£ our broad pipeline to≥γ≈ wards the clinic,” sa∞★ id Dr. Gerhard Müller, Chief Scientific Offic₩✔er of Gotham Therapeutics. “By pur£₩suing the full range of the reader-wr♣≤"iter-eraser continuum, we a≠βre able to focus on targets with the most c₽δ€ompelling links to disδ★ease and advance those progra₽∑¶ms in tandem.”“Combining Ω↔∞our high proficiency in provδ≈®£iding customized solutions as early stage drug×≠-discovery services, including taiβ¥↓lor-made biochemical and cell-based assays,±∞δ with Gotham’s expertise in eγ>♣pitranscriptomics, we werπ€∞₩e able to establish in a very s±♠&★hort time a set of customized enzymatic×♠↕ and cellular assays for compounα"★₹ds addressing three different mRNA-modif★ying targets,” said Dr. Se®÷×bastian Dempe, Chief Exe♦¥cutive Officer of ProQi'>π★nase. “We look forward to supporting Goth∏λ→$am as the company advances its ÷Ωprograms into lead optim®&ization and to continued work wi≈®≠th the Gotham team assisting the companyφ≥÷≠ to advance its broad pipeline in a time-e←∑¥ffective manner.”In addition t★¶ →o establishing a tailor↔←-made profiling cascade for compounds from it↓←s three most advanced programs, Gotham has als♥☆o made progress in strengthening i♥∞©ts drug discovery en ™$✔gine and developing its candidate base. Gotha≠®≤$m previously completed the genπλ≥ e-to-lead phase for its drug disφ₹ ♠covery project targeting↕≠↔ the METTL3/METTL14 co₹π™mplex and established a robus♥♣πt discovery process as a platform for futu&≥re projects. The compa∞®•™ny has also generated a library of high-quality ∞↔compounds tailor-made for a↕♥ccelerated hit generation and hit-to-lead₹© expansion against large parts o™<f the epitranscriptomic target space≠₩∑. This library includes a collection oδ£f over 2,000 analogues covering over 80•>∑ distinct chemotypes that will be usβφed to further accelerate Gotham’s drug÷↑® discovery efforts a→£s it expands its pipeline.The original link:https¥♣♣://www.pharmafocusas↕γia.com/news/gotham-therapeutics☆≥≈-establishes-advanceλ↓→d-oncology-profiling-c÷ascade-with-proqinase-to-progres£Ω∞s-its-portfolio-of-eδεpitranscriptomic-drug-candidates2019 Asia-✔ pacific pharma IP Lea←πder Summit: http://en.zenseegroup.com/p/51★'"•0934/will be held in Beijing ∏♦; on November 14-15, a✘↔≥nd will attract more φ÷σ★than 500 industry experts from domestic and forγ∞β∑eign pharmaceutical companies, biotec¥÷εhnology companies, governments, ass₩¥☆ ociations, law firms, intel¥±&lectual property agents and other ₽± companies to attend.Official registratio£εn and consultation channels:Co✘♦$ntact：AnnPhone: 021-65650305Email：Mark®↓♣↓eting@zenseegroup.comhttp://en.zenseegroup.cπ om/p/510934 -
1223
United Airlines to pay $321,000 to se≠÷★$ttle sexual harassment case
From:businessinsuranceU¥✘nited Airlines Inc. will pay $321,000 α±←εplus attorneys fees to settle a ←∑sexual harassment lawsuit filed↕÷£ by the U.S. Equal Employment Opportuni← ♠≠ty Commission that charged a United captain se ≠±xually harassed a flight attenda♦☆nt for many years, the agency said δε¥Friday.The EEOC said the captain frequen tly posted explicit images of the§≈¶ flight attendant to multiple ♦∞↓αwebsites without her consent, refer₩₩ring to her name, home airport and the ai≤♠¶rlines’ tagline, “Fly the Frie"↔ndly Skies.”It said aδ☆™αlso the images were seen by her co-w₩ε'orkers as well as “untold numb≠♥™ers” of potential passengers, causing h≥€ er humiliation and embarrassment and adversely af¥£→fecting her work environment.>©The EEOC said the Chicago-based airlσ©ine failed to prevent and correcΩ✔φt the pilot’s behavior ®$although the flight attendant¥Ω had made numerous complaints and pr≤★λγovided substantial evidence in th₩e matter.The EEOC said the pilot was£♠• allowed to retire with benefit≥∑₹s despite the initiation of a criminλ∑↕al prosecution by the U.S.✔ <€ attorneys office under fede"÷≤ral internet stalking law€₹&¶s.According to a 2018 new¥≠s report, after the pilotγ→ confessed and pleaded guilty and accepted ε÷&a 41-month prison sentence, United placed©≥× him on long-term disabili£ ty.The agency, which f✔βΩ≤iled its lawsuit in the case in 2018, •£₹¥had charged the airline with viola &ting Title VII of the Civil Rights Act of 1964.U∑ nder the consent decree resolving th♦" e case, in addition to paying the fli↔λ☆πght attendant $321,000"®∏$ and attorney’s fees, United m®♦φ∏ust revise its sexual h♠ §arassment policies to explicitly include haras≤'≈sment conduct perpetratδ★σ≤ed through the intern™§∑et or social media, whether o±©↑n or off duty, that affects the work envi ÷ronment,Robert A. Canino, regional attorn✘±∞ey of the EEOC’s Dallas District, said i₽β∑n the statement, “This case highlights th£↕≠e issues of employer accountability for hara₽✔↕€ssment in the modern workplace.“Empl₽πoyee workdays and jobσ☆sites are no longer defined by timecards and ✔♣the walls of a building, but by the breadth o₩f a digital day and the reach of e€✔lectronic communications.“The policy United hγσ>γas agreed to implement can perhaps serve to provε₩ide ideas for other c<∑¥ompanies adapting to thδ↑∞×e increased risks posed by employe≥φ₽≤e misuse of technology.”United Airlines ∞¥said in a statement, “The pilot’π≠βs actions were reprehensible, and he ε$is no longer a United employee. We ha×♦ve a zero-tolerance policy for any↓± type of harassment in the workplace and eλ±¥xpect our employees to treat each other with dig♥→nity and respect.“We stron§ gly disagree with theφ ' EEOC’s allegations and will continue ♥$to reinforce the procedures ¥₽≥¥and training we have in place to p&πrotect our employees fr>δ₹om sexual harassment.”Th£→§©e EEOC said Wednesday that Uber Technologies Inc.★₽£ will establish a $4.4 millio <γ•n fund to compensate anyone whom the agency≤∑ determines experien↔→™ced sexual harassment and/or related retaliation ¥®at the company after Jan. 1, 2014'φ♠.Organizer：China Insurance Digital & AI De→φvelopment 2020Web:http://e₽±n.zenseegroup.com/p/αε560573/Contact:Ann 02'♠φ♥1-65650305 -
1224
AXA XL, Slice Labs, Micros&&®βoft to Offer Cyber Risk♥ε∑✔ Management Tools
From:insurance journalAX∑♠σA XL, the p&c and Speci∑≤alty Risk Division of global insur£♠er AXA, Slice Labs Inc. (→φ&Slice), an on-demand insurer of cloud techno≈←σlogy, and Microsoft wil$↑>l work together to help improve ✘λcyber health and mitigate risks for Microsof£★§t 365 Business, Office 365 Business Premium and O∑α ©ffice 365 Business customers. The new r±φelationship will give qualifying custom§β✔ers discounted access to Slice on"♣®-demand, cloud-based cyber insurance provφ♠≠'ided by AXA XL.Microsoft customers will hav¶÷δe access to an end-to-end product that will÷Ω€ help them secure their environment and give the≤¶m the critical services and support for incident≠& response and remediation in the event o₽<f a successful cyber-attack. T÷₽hese services are all part of AXA XL’s cybeφ↑r insurance policy, which $ will be offered at d'φ↓↔iscounted pricing to qualified customers who r•∞εepresent a lower insurance risk bδ∑£♠ased on a security posture assessment that w£×σ™ill be provided by Microsoft☆<∑ Secure Score.Recent Forrester surγ• vey results found that cybersecurity attacks are ¶₩¶&a business reality for small and mid-≠¶εsize businesses (SMBs), with nearly half φ↔γ≠having had a breach within the last year$♠γ. What was more concerninπ×γ↓g was that 27% of SMBs were u∑σnaware if they’ve had a breach. One p♥πrimary issue is that 58% of theεπ σ SMBs struggle to maintain basic cybersecurity h¥∏₽ygiene.“This new levelσ<☆ of integration with Microsoft ε€ and Slice Labs reinforces the fact t♣ ±hat insurance is no longer an after t®γ✔✔he fact product that companies☆∏© should use as a band-a≤≠ <id when an incident occurs,” said John ≠<Coletti, Chief Underwriting Officer, Aβ♥βXA XL’s cyber insuran₹>ce team in North America.Small busi∏≥ness Microsoft custom÷↕ ers can access AXA XL Cyber Insura≤♦δnce offered by Slice here.Slice Labs i÷ s the insurance engine behind tomorrow’s clou↕↓↓d-based, on-demand digital services ecosys♥≠₹tems for the new economy. Through Slice’s σInsurance Cloud Service'σ≤ s (ICS) platform, Slice is enabliδ¥ng insurers, technology companie♦≤↑βs, and other service providers to build pay-as-yλ &ou-go digital insurance produc←φ®©ts protecting the insured anytime and anywhere.☆' Slice is licensed in the US ₹™and the UK.Organizer：China Insurance Dig↑ λδital & AI Development 2020Web:http Ωδ://en.zenseegroup.com/p/560573/Contact:Ann 021ε±♠-65650305 -
1225
Health Provider in Ariz ↕ona to Pay $6M Settlemen ↔₽t in Breach
A Phoenix, Ariz.-based h™≤><ealth provider has agreed&÷ to settle a lawsuit over a com↓δputer data breach thatδ™ may have compromised health and person ↑•al data of about 3 million patients, β♠'employees, health insurance cust♠☆✘omers and others.The class action lawsuitεσγ₩ against Banner Health stemmed from a 2016<∑β≈ cyberattack that exposed the inform←★→ation, The Arizona Re±™public reports.The settlement, up tΩ★∞o $6 million, includes free i♦←nsurance coverage for claims of up to $1 millio©δ>n to cover financial lo♠₩sses and two years of free ←←≥credit monitoring thro €¶λugh Identity Guard Total, officials≈δ £ said.When the breach occurred, Banner Health i•©≠πnitially gave those affected a y₩λ±ear of free credit monitoring, offi↕↔δcials said.Those affected★&$σ would be able to file claims for up t☆φo $500 for ordinary expenses or up to $10,00≤←&0 for extraordinary expense reimbursement suc∞< •h as lost time at work or professional help ☆ with identity theft issues under the seπσttlement agreement, company officials saσ•id.“All things considered, th¥is settlement compares very favorably∞< with those that have been approved ←επin other data breach cases,” said Andrew Frε★↔iedman, one of the lawyers repres₹§αenting the plaintiffs.™≠The settlement was granted §αpreliminary approval and is subject t♥o final court approval April 21, of♥☆↓ficials said.“This is st→∏ill a pending legal matter, so we are u✘¥ nable to discuss deta×£←♠ils. However, we are hopeful that it will be r≥♥esolved soon, at whic×σ★↕h time those who were impacted caπ'₩n learn additional information,” provider spokesπ±¶≤woman Becky Armendariz ∞ §said.Banner Health ha£s also agreed to improve i€©♠®ts information security systems, ∏₩επofficials said.“In the meantime, data se"£≥™curity is one of our highest prioritiesβ∞•ε and we continue to work diligφ♥γently to protect the sensitive information of o₩×↑÷ur patients and employees,” officials saiα™d.From:insurance journalOrgaε <nizer：China Insurance Digital &±×≈✔amp; AI Development 2020Web:http://en.₩≤∞↔zenseegroup.com/p/560573/Contact:Annγ≠ 021-65650305
Contact Us
Zensee_Daystar online
© 2011-2016